Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Bellicum Pharmaceuticals Inc (Bellicum) is a clinical-stage biopharmaceutical company. It primarily focuses on the development and commercialization of novel cellular immunotherapies for various forms of cancer. The company's product candidates include BPX-601 and BPX-603, that are designed to be more efficacious CAR-T cell products capable of overriding key immune inhibitory mechanisms. Bellicum's GoCAR technology builts a enhance effector cell proliferation and functional persistence and is designed to enlist wider immune cell engagement to target resistant tumor cells. Its therapies are primarily targeted towards cancer patients, aiming to provide more effective treatment options. The company operates in the US. Bellicum is headquartered in Houston, Texas, the US.
Headquarters
United States of America
Address
Suite 1200, 3730 Kirby Drive, Houston, Texas, 77098
Website
www.bellicum.com
Telephone
1 281 4543424
No of Employees
13
Industry
Pharmaceuticals and Healthcare
Revenue (2022)
$1.5M
Products and Services
| Products |
|---|
| Pipeline |
| GoCAR-T: |
| BPX-601 |
| XYZ |
| XYZ |
| XYZ |
Competitor Comparison
| Key Parameters | Bellicum Pharmaceuticals Inc | Cellectis SA | ImmunityBio Inc | COSCIENS Biopharma Inc | Northwest Biotherapeutics Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | France | United States of America | Canada | United States of America |
| City | Houston | Paris | San Diego | Toronto | Bethesda |
| State/Province | Texas | Ile-de-France | California | Ontario | Maryland |
| No. of Employees | 13 | 224 | 673 | 21 | 25 |
| Entity Type | Private | Public | Public | Public | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Jon P. Stonehouse | Chairman | Executive Board | - | - |
| Richard A. Fair | Chief Executive Officer; President; Director | Executive Board | - | - |
| Charles S. Grass | Principal Accounting Officer | Senior Management | 2023 | - |
| Judith Klimovsky | Director | Non Executive Board | 2023 | - |
| Stephen R. Davis | Director | Non Executive Board | 2023 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer